عربي
English
Quick links
Related sites
Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Login area | Sign up
Forgot your password? Click here
Let us help you
Read about the latest topics.
Download the new version of the MOPH app 
for the latest updates on Coronavirus
 
Be Responsible
#Raise your voice
Send us any Fraudulent Action or Enquiry so we can ALL contribute to make a Difference

Request for Quotation for Accessories for COVID-19 Vaccine

 
Country: Lebanon
Name of Project: Lebanon Health Resilience Project (LHRP)
Contract Title: Accessories for COVID-19 Vaccine
Loan No.: P163476
RFQ Reference No.: LB-MOPH-RFQ006
 
  1. The Government of Lebanon has received financing from the World Bank toward the cost of the Lebanon Health Resilience Project (LHRP) and intends to apply part of the proceeds toward payments under the contract for Procurement of Accessories for COVID-19 Vaccine. 
  2. The Lebanese Ministry of Public Health now invites quotations from eligible Bidders for syringe, latex gloves, alcohol pads, sterile NaCl ampoules, plastic sharp containers and temperature monitors to be delivered to the ministry’s warehouse at Al Quarantina Beirut within a period not exceeding one month from contract signature.
  3. Bidding will be conducted through international competitive procurement using a Request for Quotation (RFQ) as specified in the World Bank’s “Procurement Regulations for IPF Borrowers” dated July 2016 revised in November 2017 and August 2018 (“Procurement Regulations”) and is open to all eligible Bidders as defined in the Procurement Regulations.
  4. Interested eligible Bidders may obtain further information from
Agency: Ministry of Public Health
Officer: Mr. Ibrahim Assaad
Email: ibrahim.a.moph@gmail.com
  1. The quotation in English may be obtained by interested suppliers upon the submission of a written request to the address below. The document will be sent by electronic mail.
  2. Quotations must be delivered to the address below on or before Friday, March 12, 2021 at 13:00 local time. Quotations by email are acceptable. Late Bids will be rejected.
  3. The address referred to above is:
Name: Ibrahim Assaad
Title: Operations Assistant
Location: MOPH, Beer Hassan, Beirut, Lebanon
Phone number: +961 1 830 300 ext: 274
Email address: ibrahim.a.moph@gmail.com
Website: https://www.moph.gov.lb/
 
    1
    ...
    31
    32
    33
    34
    35
    36
    ...
    178
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
All
ATC Name B/G Ingredients Dosage Form Price
J01CR02 AUGMENTIN B Amoxicillin (trihydrate) - 250mg/5ml, Clavulanic Acid (potassium) - 62.5mg/5ml 312.5mg/5ml Powder for suspension 542,912 L.L
L01ED01 XALKORI B Crizotinib - 200mg 200mg Capsule 347,644,061 L.L
N03AX23 BRIVIACT B Brivaracetam - 50mg 50mg Tablet, film coated 9,627,931 L.L
N06AB10 CIPRALEX B Escitalopram (oxalate) - 15mg 15mg Tablet, film coated 2,378,601 L.L
B01AC04 PLAVIX B Clopidogrel (hydrogenosulfate) - 75mg 75mg Tablet, film coated 1,350,562 L.L
D06BX01 ROZEX B Metronidazole - 0.75g/100g 0.75% Gel 584,571 L.L
G04BD07 DETRUSITOL B Tolterodine (tartrate) - 2mg 2mg Tablet, film coated 1,995,606 L.L
L01ED03 ALECENSA B Alectinib - 150mg 150mg Capsule, hard 490,837,809 L.L
M01AE03 PROFEMIGR B Ketoprofen - 150mg 150mg Tablet, scored 302,365 L.L
N02AX02 TRAMAL RETARD B Tramadol HCl - 100mg 100mg Tablet, modified release 236,516 L.L
N03AX23 BRIVIACT B Brivaracetam - 10mg/ml 10mg/ml Solution 10,314,804 L.L
R07AA INFASURF B Calfactant - 210mg/6ml 35mg/ml Injectable suspension 40,596,749 L.L
C09AA03 ZESTRIL B Lisinopril (dihydrate) - 10mg 10mg Tablet 592,635 L.L
L01ED04 ALUNBRIG B Brigatinib - 30mg 30mg Tablet, film coated 113,539,160 L.L
M01AE03 PROFENID B Ketoprofen - 100mg 100mg Tablet, film coated 469,001 L.L
N02AX02 TRAMAL RETARD B Tramadol HCl - 150mg 150mg Tablet, modified release 356,118 L.L
R07AA INFASURF B Calfactant - 105mg/3ml 35mg/ml Injectable suspension 23,344,161 L.L
C09AA03 ZESTRIL B Lisinopril (dihydrate) - 20mg 20mg Tablet 636,981 L.L
C10AA01 ZOCOR B Simvastatin - 40mg 40mg Tablet 1,435,992 L.L
G04BD08 VESICARE B Solifenacin succinate - 5mg 5mg Tablet, film coated 1,619,330 L.L
J01FF01 DALACIN-C B Clindamycin HCl - 150mg 150mg Capsule 287,582 L.L
L01ED04 ALUNBRIG B Brigatinib - 90mg 90mg Tablet, film coated 340,619,684 L.L
N02AX02 TRAMAL RETARD B Tramadol HCl - 200mg 200mg Tablet, modified release 474,376 L.L
N04BA02 SINEMET B Levodopa - 250mg, Carbidopa - 25mg Tablet, scored 1,283,690 L.L
R07AA01 SURVANTA B Colfosceril palmitate - 200mg/8ml 200mg/8ml Suspension 36,957,499 L.L
A10BD02 GLUCOVANCE B Metformin HCl - 500mg, Glibenclamide - 2.5mg Tablet, film coated 513,273 L.L
D07AB02 LOCOID B Hydrocortisone butyrate - 1mg/g 0.1% Cream 215,015 L.L
J01CR02 AUGMENTIN B Amoxicillin (trihydrate) - 400mg/5ml, Clavulanic Acid (potassium) - 57mg/5ml 457mg/5ml Powder for suspension 524,099 L.L
J01FF01 DALACIN-C B Clindamycin HCl - 300mg 300mg Capsule 478,408 L.L
L01ED04 ALUNBRIG B Brigatinib - 180mg 180mg Tablet, film coated 449,469,674 L.L
    1
    ...
    31
    32
    33
    34
    35
    36
    ...
    178
Sitemap
© Copyrights reserved to Ministry of Public Health 2025